Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
Having supplanted Novartis as the biggest pharma company by prescription sales in 2019, Roche managed to hang onto the title in 2020 (Fig. 1a). This success came despite lower sales than 2019, as some of its biggest drugs, including multiple sclerosis treatment Ocrevus (ocrelizumab), were hit early in the pandemic owing to hospitals delaying treatments and focusing on COVID-19.